Biomarker
A measurable substance in blood, tissue or urine that reflects a biological state — the inputs your clinician uses to choose the right protocol.
Definition
Biomarkers are objective, reproducible measurements that indicate a normal or pathologic process. In peptide medicine, the most decision-shaping biomarkers are IGF-1 (growth-hormone axis), hs-CRP (systemic inflammation), HbA1c and fasting insulin (metabolic health), and full CBC/CMP panels for safety. The Peptide Readiness Panel captures the minimum set needed before prescribing most protocols.
Read More
IGF-1Insulin-like Growth Factor 1
The primary blood marker of growth-hormone activity — the lab that gates any GH-axis protocol and the one re-checked at month 3.
Biomarkerhs-CRPHigh-Sensitivity C-Reactive Protein
A sensitive inflammation marker — elevated values change which peptides a clinician selects and at what dose.
BiomarkerHbA1cGlycated Haemoglobin
A blood marker of average glucose over the prior 3 months — the standard metric for diabetes screening and GH-axis protocol safety.
$149 panel.
A clinician reads it in 24 hours.
Order the Peptide Readiness Panel, draw at a Quest or LabCorp near you, and your clinician sends back a matched protocol with a confidence score.